Clinical interest in semaglutide-induced loss of lean mass is increasing, which is particularly relevant in a post-MBS population likely to experience surgery-induced loss of lean mass
If sugar is withdrawn too abruptly, the vessel walls come under stress
Hims & Hers Health stock tanks after FDA says competitor Eli Lillys weight-loss drug shortage is over Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S
A GLP-1 drug can blunt the appetite, but the habits, the food environment, and the patterns remain
They address chronic health conditions, helping reduce cardiovascular disease risk, improve blood pressure levels, and better manage metabolic diseases like type 2 diabetes
Appetite effects, if they occur, typically emerge around weeks 3 to 4